Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy in urban space, areas of risk for disability and worsening of this health condition in Foz Do Iguaçu, the border region between Brazil, Paraguay and Argentina.

Simionato de Assis I, Berra T, Alves LS, et al. BMC public health. 2020; 20 (1) : 119.
Download PDF
Publication

Women from the Federation of Societies for the Care of [L....s] and Defense Against Leprosy, 1926-1947.

Santos F, Leandro J. Historia, ciencias, saude--Manguinhos. 2020; 26 (suppl 1) : 57-78.
Publication

Clinical characteristics of neuropathic pain in leprosy and associated somatosensory profiles: a deep phenotyping study in India.

Haroun O, Vollert J, Lockwood DN, et al. Pain reports. 2019; 4 (6) : e743.
Download PDF
Publication

Human Genetic Susceptibility of Leprosy Recurrence.

Sartori P, Penna G, Bührer-Sékula S, et al. Scientific reports. 2020; 10 (1) : 1284.
Download PDF
Publication

Considerations for Improved mHealth Evaluation: Retrospective Qualitative Investigation (Preprint)

Dick S, O'Connor Y, Thompson M, et al. JMIR Publications Inc.. JMIR mHealth and uHealth. 2020;
Download PDF
Publication

Prevention of transmission of leprosy: The current scenario.

Palit A, Kar HK. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123.
Download PDF
Publication

FAMIN Is a Multifunctional Purine Enzyme Enabling the Purine Nucleotide Cycle.

Cader ZM, Rodrigues R, West J, et al. Cell. 2020; 180 (2) : 278-295.e23.
Download PDF
Publication

ILEP's research into discriminatory laws: legislation

ILEP. 2019;
Download PDF
Publication

"Equipping Practitioners": Linking Neglected Tropical Diseases and Human Rights.

Amon J, Addiss D. Health and human rights. 2018; 20 (1) : 5-10.
Download PDF
Publication

Towards a toolkit for cross-neglected tropical disease morbidity and disability assessment.

van 't Noordende A, Kuiper H, Ramos AN, et al. International health. 2016;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 398
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD